Yahong Pharmaceutical: Product APLD - 2304 has been accepted for European medical device registration.

Yahong Pharmaceuticals announced that their product APLD-2304 has recently submitted medical device registration materials to the European Union regulatory agency and has been accepted. It will need to go through evaluation and approval before it can be marketed. This product is the first portable disposable blue light bladder endoscope, which, when combined with blue light imaging agents, can increase the detection rate of bladder cancer and reduce recurrence rates. With over 130,000 new cases of bladder cancer in Europe each year, this product has high potential in the monitoring market. However, the acceptance of this submission will not have a significant impact on the company's recent performance, as there is uncertainty in product research and approval. Investors are reminded to be aware of the risks.